Filing Details
PURE BIOSCIENCE, INC. (OTC:PURE) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 29, 2026.
The Consumer Defensive company's annual report covers fiscal year 2026.
10k filedOTC:PURE
PURE BIOSCIENCE, INC. (PURE) Files Annual Report with SEC
PURE BIOSCIENCE, INC. (OTC:PURE) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 29, 2026.
At publication ·
What changed
PURE BIOSCIENCE, INC. (OTC:PURE) · 10k filed
- Form
- 10-K
At a glance
Key takeaways
- PURE BIOSCIENCE, INC. filed its fiscal 2026 annual report (Form 10-K) with the SEC on October 29, 2026.
- The company's stock trades at $0.08 per share with a market capitalization of $5.4 million.
- The 10-K filing includes financial statements, management analysis, risk factors, and business segment details for the full fiscal year.
Market Context
PURE BIOSCIENCE, INC.'s stock currently trades at $0.08 with a market capitalization of $5.4M.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For PURE BIOSCIENCE, INC. investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for PURE BIOSCIENCE, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PURE Stock Page
Frequently Asked Questions
Where can I read PURE's SEC filings?
Browse all filings on our PURE SEC filings page.
What types of SEC filings does PURE BIOSCIENCE, INC. file?
Public companies like PURE BIOSCIENCE, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.